Hester Biosciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
HESTERBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Hester Biosciences has informed the exchanges that its trading window for dealing in equity shares will be closed from 1 April 2026, in line with SEBI's Prohibition of Insider Trading Regulations. The window will reopen 48 hours after the company's financial results for the quarter and year ended 31 March 2026 are made public. This means directors, promoters, designated employees, and connected persons are barred from trading in the stock during this period. The closure is a standard compliance step taken ahead of the announcement of Q4 and full-year FY2026 results.
This is a routine regulatory filing and not material to the stock price, but it signals that the company's Q4 and FY2026 earnings announcement is imminent. Retail investors should watch for the upcoming results, which could be a near-term catalyst.